Puma Biotechnology (PBYI) Abstract Data Helps Explain Need to Change Trial - RBC
Go back to Puma Biotechnology (PBYI) Abstract Data Helps Explain Need to Change Trial - RBC| PUMA BIOTECHNOLOGY, Inc. (NASDAQ: PBYI) | Delayed: 5.01 +0.02 (0.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.99 | 52 Week High | $82.81 | |||
| Open | $4.92 | 52 Week Low | $19.74 | |||
| Day High | $5.08 | P/E | N/A | |||
| Day Low | $4.90 | EPS | $-2.16 | |||
| Volume | 289,863 | |||||
